Feature Channels: Cell Biology

Filters close
Released: 16-May-2023 2:00 PM EDT
May is Melanoma and Skin Cancer Awareness Month. Keep up with the latest news on skin in the Dermatology channel
Newswise

Skin cancer is the most prevalent form of cancer in the United States, with over 5 million cases diagnosed annually. The Centers for Disease Control and Prevention reports that melanoma alone accounts for more than 8,000 deaths each year. Thankfully, skin cancer is highly preventable, making it crucial to prioritize protection. Below are some of the latest headlines in the Dermatology channel.

Newswise: You’ve got some nerve
Released: 16-May-2023 12:45 PM EDT
You’ve got some nerve
Michigan Medicine - University of Michigan

Researchers at the University of Michigan Rogel Cancer Center and the School of Dentistry identified a new metric to articulate the relationship between nerve density and oral cancer.

Newswise: Timing is everything: New insights into floral development unveil nature's perfect clock
Released: 16-May-2023 12:10 PM EDT
Timing is everything: New insights into floral development unveil nature's perfect clock
Nara Institute of Science and Technology

The intricate process of flower development has long fascinated scientists seeking to unravel the mysteries behind nature's precision timing.

Newswise: Engineers building tools to improve quality, production of disease-fighting cells
Released: 16-May-2023 12:05 PM EDT
Engineers building tools to improve quality, production of disease-fighting cells
Iowa State University

Iowa State University engineers are developing advanced tools for cell manufacturing that could improve the cost and availability of therapeutic cells capable of fighting diseases such as cancers, heart disease, lupus and other autoimmune diseases.

   
Released: 16-May-2023 9:30 AM EDT
Penn Medicine at the American Society of Gene and Cell Therapy 26th Annual Meeting
Perelman School of Medicine at the University of Pennsylvania

Researchers from the Gene Therapy Program (GTP) at the Perelman School of Medicine at the University of Pennsylvania will present nine abstracts highlighting their translational science and discovery research on gene therapy, gene editing, and adeno-associated virus (AAV) vector technology at the American Society of Cell and Gene Therapy (ASGCT) 26th Annual Meeting on May 16–20, 2023 in Los Angeles, California.

Newswise: Antibodies associated with rare disorder may signal future risk of heart attack and stroke
Released: 16-May-2023 8:05 AM EDT
Antibodies associated with rare disorder may signal future risk of heart attack and stroke
UT Southwestern Medical Center

Seemingly healthy people whose blood contained antibodies associated with a condition called antiphospholipid syndrome (APS) were significantly more likely to experience a cardiovascular event such as a heart attack or stroke than those without, a study led by UT Southwestern Medical Center scientists shows

Newswise: Novel AI-based software enables quick and reliable imaging of proteins in cells
Released: 15-May-2023 6:35 PM EDT
Novel AI-based software enables quick and reliable imaging of proteins in cells
Max Planck Institute of Molecular Physiology

In a cryo-ET experiment, scientists use a transmission electron microscope to obtain 3D images, called tomograms, of the cellular volume containing complex biomolecules.

Newswise: Newly discovered RNA molecules hold promise for detecting and treating esophageal cancer
Released: 15-May-2023 4:45 PM EDT
Newly discovered RNA molecules hold promise for detecting and treating esophageal cancer
Case Western Reserve University

Irregularities in the body’s genetic coding to make proteins are linked to cancerous tumors. But most genetic material contains elements whose function isn’t clear. Could abnormalities in non-coding material also impact a person’s health, or even be linked to cancers as well? A new study by researchers at the Case Western Reserve University School of Medicine suggests that the non-coding genetic molecules also play a key role in health and disease, including tumor development.

Newswise: Immune cells of the brain are not all the same – new research could open novel therapeutic pathways
Released: 15-May-2023 12:05 PM EDT
Immune cells of the brain are not all the same – new research could open novel therapeutic pathways
University of Helsinki

A recent study published in Nature Neuroscience indicates that, contrary to common belief, the immune cells of the brain, known as microglia, are not all the same.

Newswise: WFIRM bioprinting research makes history when it soars to the ISS
Released: 15-May-2023 8:00 AM EDT
WFIRM bioprinting research makes history when it soars to the ISS
Atrium Health Wake Forest Baptist

The Wake Forest Institute for Regenerative Medicine (WFIRM) will make history this month when the first bioprinted solid tissue constructs soar to the International Space Station (ISS) on board the next all private astronaut mission by commercial space leader Axiom Space.

   
Released: 12-May-2023 5:20 PM EDT
Researchers discover a way to improve nonviral gene editing as well as a new type of DNA repair
University of California, Santa Barbara

Gene editing is a powerful method for both research and therapy. Since the advent of the Nobel Prize-winning CRISPR/Cas9 technology, a quick and accurate tool for genome editing discovered in 2012, scientists have been working to explore its capabilities and boost its performance.

   
Newswise: TTUHSC El Paso Researchers Receive Over $1.5 Million in Cancer Research Grants
Released: 12-May-2023 10:00 AM EDT
TTUHSC El Paso Researchers Receive Over $1.5 Million in Cancer Research Grants
Texas Tech University Health Sciences Center El Paso

At TTUHSC El Paso, addressing health disparities remains at the forefront of our mission.

Newswise: Study Reveals How Fatty Liver Promotes Colorectal Cancer Spread
Released: 11-May-2023 5:40 PM EDT
Study Reveals How Fatty Liver Promotes Colorectal Cancer Spread
Cedars-Sinai

Investigators at Cedars-Sinai Cancer found that fatty liver, a condition closely associated with obesity, promotes the spread of colorectal cancer to the liver. Their study, published today in the peer-reviewed journal Cell Metabolism, details the process at the cellular level and could change the way doctors manage the disease in some patients.

Newswise: Targeting uncontrolled inflammation may hold the key to treating therapy-resistant cancers
Released: 11-May-2023 1:15 PM EDT
Targeting uncontrolled inflammation may hold the key to treating therapy-resistant cancers
Van Andel Institute

Van Andel Institute scientists have pinpointed how a specific gene mutation triggers an inflammatory cascade that may drive development of treatment-resistant cancers.

Newswise: Van Andel Institute, Washington University School of Medicine in St. Louis to lead genome center under $140M NIH initiative
Released: 11-May-2023 1:10 PM EDT
Van Andel Institute, Washington University School of Medicine in St. Louis to lead genome center under $140M NIH initiative
Van Andel Institute

Van Andel Institute’s Hui Shen, Ph.D., and Washington University School of Medicine in St. Louis’s Ting Wang, Ph.D., will co-lead a collaborative project supported by the Somatic Mosaicism across Human Tissues (SMaHT) Network, a new $140 million National Institutes of Health-led effort to better understand the genetic differences between individual cells and tissues in the body.

   
Newswise: UT Southwestern researchers discover mechanism responsible for genome rearrangements
Released: 11-May-2023 12:45 PM EDT
UT Southwestern researchers discover mechanism responsible for genome rearrangements
UT Southwestern Medical Center

The goal of every dividing cell is to accurately segregate its genome into two genetically identical daughter cells. However, this process often goes awry and may be responsible for a new class of chromosomal abnormalities found in cancers and congenital disorders, UT Southwestern Medical Center scientists report in a new study. The discovery, published in Nature, sheds light on how cancer cells rapidly evolve genomic changes that fuel their proliferation.

Released: 11-May-2023 11:05 AM EDT
Researchers discover a way to improve nonviral gene editing as well as a new type of DNA repair
University of California, Santa Barbara

Gene editing is a powerful method for both research and therapy. Since the advent of the Nobel Prize-winning CRISPR/Cas9 technology, a quick and accurate tool for genome editing discovered in 2012, scientists have been working to explore its capabilities and boost its performance.

10-May-2023 6:30 PM EDT
Next-generation statistical simulator gives medical and biological researchers a benchmarking tool capable of closely mimicking single-cell and spatial genomics data
University of California, Los Angeles (UCLA), Health Sciences

UCLA researchers have developed an “all-in-one,” next-generation statistical simulator capable of assimilating a wide range of information to generate realistic synthetic data and provide a benchmarking tool for medical and biological researchers who use advanced technologies to study diseases and potential therapies.

   
Released: 10-May-2023 2:00 PM EDT
MD Anderson Research Highlights for May 10, 2023
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

   
Released: 10-May-2023 1:20 PM EDT
Ludwig Lausanne’s Douglas Hanahan Elected Foreign Member of the Royal Society
Ludwig Cancer Research

Ludwig Cancer Research congratulates Douglas Hanahan, Ludwig Distinguished Scholar at the Lausanne Branch of the Ludwig Institute for Cancer Research, on his election as Foreign Member of the Royal Society.

   
Newswise: The Acute Problem of Chronic Disease
Released: 10-May-2023 1:05 PM EDT
The Acute Problem of Chronic Disease
University of California San Diego

In medicine and science, the term “pathogenesis” describes the origin and development of disease. There is not, however, a broadly accepted term to describe the other half of the equation: the process of healing and recovery.

Released: 10-May-2023 12:35 PM EDT
AI developed in the UK is the world leader in identifying the location and expression of proteins
University of Surrey

A new advanced artificial intelligence (AI) system has shown world-leading accuracy and speed in identifying protein patterns within individual cells.

   
Newswise:Video Embedded study-of-cancer-metastasis-most-common-cause-of-cancer-death-gets-35-million-boost-at-johns-hopkins-medicine
VIDEO
Released: 10-May-2023 9:25 AM EDT
Study of Cancer Metastasis, Most Common Cause of Cancer Death, Gets $35 Million Boost at Johns Hopkins Medicine
Johns Hopkins Medicine

With a $35 million gift from researcher, philanthropist and race car driver Theodore Giovanis, scientists at Johns Hopkins Medicine will study the biological roots of the most fatal aspect of cancer: how it metastasizes, or spreads, through the body.

Newswise: Ultra-long protein fibrils give clues on dementia risk
Released: 9-May-2023 3:05 AM EDT
Ultra-long protein fibrils give clues on dementia risk
Empa, Swiss Federal Laboratories for Materials Science and Technology

During the course of Alzheimer's disease, protein fibrils appear in the spinal fluid of affected individuals. Empa researchers, together with the Department of Neurology at the Cantonal Hospital in St. Gallen, have now visualized the wide spectrum of protein aggregates from oligomers, protofibrils to fibrils in the spinal fluid.

Newswise: Virginia Tech researchers join together on cancer prevention, diagnosis and treatment
Released: 9-May-2023 2:05 AM EDT
Virginia Tech researchers join together on cancer prevention, diagnosis and treatment
Virginia Tech

May is a month to recognize the importance of cancer research, with both Brain Tumor Awareness Month and National Cancer Research Month taking center stage. Virginia Tech’s Fralin Biomedical Research Institute at VTC is dedicated to advancing our understanding of cancer and developing new ways to treat and prevent it. Teams of investigators are working to uncover the molecular mechanisms that drive cancer growth, migration, and metastasis.

Released: 8-May-2023 3:45 PM EDT
UC Irvine scientists develop gene silencing DNA enzyme that can target a single molecule
University of California, Irvine

Researchers from the University of California, Irvine have developed a DNA enzyme – or DNAzyme – that can distinguish between two RNA strands inside a cell and cut the disease-associated strand while leaving the healthy strand intact. This breakthrough “gene silencing” technology could revolutionize the development of DNAzymes for treating cancer, infectious diseases and neurological disorders.

Newswise: T Cells Can Activate Themselves to Fight Tumors
Released: 8-May-2023 11:30 AM EDT
T Cells Can Activate Themselves to Fight Tumors
University of California San Diego

UC San Diego scientists find an auto-signaling mechanism driving the T cell anti-tumor response; findings may inspire new cancer therapeutics and biomarkers.



close
5.17302